131 related articles for article (PubMed ID: 10663670)
21. Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patients.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Zirbes TK; Birnbaum F; Kressmann C; Melguizo-Grahmann M; Frackenpohl H; Sprungmann C; Leder LD; Diehl V; Zankovich R; Schaefer HE; Niederle N; Fischer R
Leuk Lymphoma; 2000 Jan; 36(3-4):295-308. PubMed ID: 10674901
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow histopathology in chronic myelogenous leukemia (CML)--evaluation of distinctive features with clinical impact.
Thiele J; Kvasnicka HM; Fischer R
Histol Histopathol; 1999 Oct; 14(4):1241-56. PubMed ID: 10506940
[TBL] [Abstract][Full Text] [Related]
23. [Clinico-hematological characteristics of acute transformation of chronic myeloproliferative syndromes].
Hernández JM; San Miguel JF; González M; Moraleda JM; Moro MJ; Hernández J; Cuesta B; López Borrasca A
Med Clin (Barc); 1991 Sep; 97(10):369-72. PubMed ID: 1745085
[TBL] [Abstract][Full Text] [Related]
24. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
25. Modern diagnostics in chronic myeloproliferative diseases (CMPDs).
Haferlach T; Kern W; Schnittger S; Schoch C
Ann Hematol; 2004; 83 Suppl 1():S59-61. PubMed ID: 15124674
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
Macavei I; Galatâr N
Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
[TBL] [Abstract][Full Text] [Related]
27. Erythropoiesis in CML--immunomorphometric quantification, PCNA-reactivity, and influence on survival.
Thiele J; Hoefer M; Kvasnicka HM; Bertsch HP; Zankovich R; Fischer R
Hematol Pathol; 1993; 7(4):239-49. PubMed ID: 7906686
[TBL] [Abstract][Full Text] [Related]
28. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
Panteli K; Zagorianakou N; Bai M; Katsaraki A; Agnantis NJ; Bourantas K
Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
[TBL] [Abstract][Full Text] [Related]
29. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
30. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
31. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
Udomsakdi-Auewarakul C; U-Pratya Y; Boonmoh S; Vatanavicharn S
J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
[TBL] [Abstract][Full Text] [Related]
32. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.
Thiele J; Kvasnicka HM
Ann Hematol; 2003 Mar; 82(3):148-52. PubMed ID: 12634946
[TBL] [Abstract][Full Text] [Related]
33. Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population.
Rudzki Z; Papla B; Stachura J
Pol J Pathol; 2004; 55(1):13-23. PubMed ID: 15195702
[TBL] [Abstract][Full Text] [Related]
34. [Thrombocytosis versus thrombocythemia--differential diagnosis of elevated platelet count].
Thiele J; Kvasnicka HM
Pathologe; 2000 Jan; 21(1):31-8. PubMed ID: 10663667
[TBL] [Abstract][Full Text] [Related]
35. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
36. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Ann Hematol; 2001 Mar; 80(3):160-5. PubMed ID: 11320901
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of chronic myeloproliferative syndromes using the technics of in vitro hematopoiesis (the origin and function of marrow stromal cells in CML)].
Takahashi M; Fujiwara M
Rinsho Ketsueki; 1988 Jul; 29(7):994-1000. PubMed ID: 3184486
[No Abstract] [Full Text] [Related]
38. Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis--features of significance for the diagnosis of primary (essential) thrombocythaemia.
Thiele J; Schneider G; Hoeppner B; Wienhold S; Zankovich R; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):407-17. PubMed ID: 3140482
[TBL] [Abstract][Full Text] [Related]
39. [Use of interferon in the treatment of chronic myeloproliferative disorders].
Robak T
Acta Haematol Pol; 1992; 23(2 Suppl 1):30-7. PubMed ID: 1488870
[TBL] [Abstract][Full Text] [Related]
40. Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial.
Buesche G; Hehlmann R; Hecker H; Heimpel H; Heinze B; Schmeil A; Pfirrmann M; Gomez G; Tobler A; Herrmann H; Kappler M; Hasford J; Buhr T; Kreipe HH; Georgii A
Leukemia; 2003 Dec; 17(12):2444-53. PubMed ID: 14562117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
